Adverse perinatal outcomes in gestational diabetes mellitus with and without SARS-CoV-2 infection during pregnancy: results from two nationwide registries in Germany.

COVID-19 Diabetes, Gestational Pregnancy Outcome

Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
25 Jan 2024
Historique:
received: 25 08 2023
accepted: 29 12 2023
medline: 26 1 2024
pubmed: 26 1 2024
entrez: 25 1 2024
Statut: epublish

Résumé

Pregnancy is a known independent risk factor for a severe course of COVID-19. The relationship of SARS-CoV-2 infection and gestational diabetes mellitus (GDM) on neonatal outcomes is unclear. Our aim was to determine if SARS-CoV-2 infection represents an independent risk factor for adverse perinatal outcomes in pregnancy with GDM. We compared data from two German registries including pregnant women with GDM, established during the SARS-CoV-2 pandemic (COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS), a multicenter prospective observational study) and already existing before the pandemic (German registry of pregnant women with GDM; GestDiab). In total, 409 participants with GDM and SARS-CoV-2 infection and 4598 participants with GDM, registered 2018-2019, were eligible for analyses. The primary fetal and neonatal outcomes were defined as: (1) combined: admission to neonatal intensive care unit, stillbirth, and/or neonatal death, and (2) preterm birth before 37+0 weeks of gestation. Large and small for gestational age, maternal insulin therapy, birth weight Women with SARS-CoV-2 infection were younger (32 vs 33 years) and had a higher median body mass index (28 vs 27 kg/m²). In CRONOS, more neonates developed the primary outcome (adjusted OR (aOR) 1.48, 95% CI 1.11 to 1.97) and were born preterm (aOR 1.50, 95% CI 1.07 to 2.10). Fasting glucose was higher in women in CRONOS versus GestDiab (5.4 vs 5.3 mmol/L) considering each 0.1 mmol/L increase was independently associated with a 5% higher risk of preterm birth among women in CRONOS only (aOR 1.05, 95% CI 1.01 to 1.09). GDM with SARS-CoV-2 infection in pregnancy is associated with an increased risk of adverse fetal and neonatal outcomes as compared with GDM without SARS-CoV-2 infection.

Identifiants

pubmed: 38272538
pii: 12/1/e003724
doi: 10.1136/bmjdrc-2023-003724
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Tatjana P Liedtke (TP)

Institute for Epidemiology, Kiel University, Kiel, Germany.

Katharina S Weber (KS)

Institute for Epidemiology, Kiel University, Kiel, Germany.

Heinke Adamczewski (H)

Scientific Institute of Diabetologists in Practice, Kaarst, Germany.

Dietmar Weber (D)

Scientific Institute of Diabetologists in Practice, Kaarst, Germany.

Babett Ramsauer (B)

Department of Gynecology and Obstetrics, Vivantes Clinic Neukölln, Berlin, Germany.

Ute M Schaefer-Graf (UM)

Department of Obstetrics, Berlin Diabetes Center for Pregnant Women, St. Joseph Hospital, Berlin, Germany.

Tanja Groten (T)

Department of Obstetrics, Competence Center for Diabetic Women, Jena University Hospital, Jena, Germany.

Eike A Strathmann (EA)

Institute for Epidemiology, Kiel University, Kiel, Germany.

Wolfgang Lieb (W)

Institute for Epidemiology, Kiel University, Kiel, Germany.

Mario Rüdiger (M)

Saxony Center for Fetal-Neonatal Health, Faculty of Medicine and University Hospital Carl Gustav Carus, Technical University, Dresden, Germany.

Ulrich Pecks (U)

Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Maternal Health and Midwifery Science, Julius Maximilians University of Würzburg, Würzburg, Germany.

Classifications MeSH